Vestmark Advisory Solutions’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Buy |
+1,927
| New | +$214K | ﹤0.01% | 751 |
|
|
2023
Q3 | – | Sell |
-14,552
| Closed | -$1.12M | – | 594 |
|
|
2023
Q2 | $1.12M | Sell |
14,552
-2,475
| -15% | -$191K | 0.04% | 427 |
|
|
2023
Q1 | $1.41M | Sell |
17,027
-2,968
| -15% | -$246K | 0.06% | 352 |
|
|
2022
Q4 | $1.72M | Buy |
19,995
+897
| +5% | +$77K | 0.08% | 303 |
|
|
2022
Q3 | $1.18M | Sell |
19,098
-1,378
| -7% | -$85K | 0.07% | 341 |
|
|
2022
Q2 | $1.27M | Buy |
20,476
+465
| +2% | +$28.8K | 0.07% | 311 |
|
|
2022
Q1 | $1.19M | Buy |
20,011
+932
| +5% | +$55.4K | 0.07% | 321 |
|
|
2021
Q4 | $1.39M | Sell |
19,079
-7
| -0% | -$508 | 0.08% | 303 |
|
|
2021
Q3 | $1.33M | Buy |
19,086
+7,160
| +60% | +$500K | 0.09% | 286 |
|
|
2021
Q2 | $821K | Sell |
11,926
-10
| -0.1% | -$688 | 0.06% | 363 |
|
|
2021
Q1 | $771K | Buy |
11,936
+556
| +5% | +$35.9K | 0.07% | 347 |
|
|
2020
Q4 | $663K | Sell |
11,380
-545
| -5% | -$31.8K | 0.07% | 306 |
|
|
2020
Q3 | $754K | Buy |
11,925
+245
| +2% | +$15.5K | 0.1% | 261 |
|
|
2020
Q2 | $899K | Sell |
11,680
-4,662
| -29% | -$359K | 0.14% | 212 |
|
|
2020
Q1 | $1.22M | Sell |
16,342
-4,840
| -23% | -$362K | 0.24% | 133 |
|
|
2019
Q4 | $1.38M | Sell |
21,182
-239
| -1% | -$15.5K | 0.28% | 128 |
|
|
2019
Q3 | $1.36M | Buy |
21,421
+4,682
| +28% | +$297K | 0.22% | 142 |
|
|
2019
Q2 | $1.13M | Buy |
16,739
+8,298
| +98% | +$561K | 0.19% | 160 |
|
|
2019
Q1 | $549K | Buy |
+8,441
| New | +$549K | 0.1% | 260 |
|